psychotherapy within 3 months prior to consent.
Discontinuation criteria included intolerably adverse
events from fluoxetine treatment, cooperation
difficulties with CBT, so much improvement of
symptoms such that it was not necessary to continue
CBT, consent withdrawal, loss to follow-up more
than 4 weeks and finally judgment of the therapist
with the patient’s approval that it was beneficial to
discontinue CBT.
dependence (except nicotine and caffeine), moderate
to severe suicidal behavior as per the MADRS, a
general medical condition preventing continuation
or treatment response and having received any